<DOC>
	<DOCNO>NCT00151983</DOCNO>
	<brief_summary>This study ass safety tolerability MTS attempt establish appropriate start dose subject previously exist long-acting methylphenidate product .</brief_summary>
	<brief_title>Safety &amp; Tolerability MTS Children Aged 6-12 Diagnosed With ADHD &amp; Previously Treated With Extended-Release Methylphenidate Therapy</brief_title>
	<detailed_description>Attention-Deficit/Hyperactivity Disorder ( ADHD ) psychiatric disorder characterize 3 main symptom : inattention , hyperactivity impulsivity . This study ass safety tolerability SPD485 attempt establish appropriate start dose subject previously exist long-acting methylphenidate product .</detailed_description>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<criteria>Subject must primary diagnosis ADHD Subject must adequately control stable dose one follow medication 30 day period : Ritalin LA ( r ) , Concerta ( r ) , Metadate DC ( r ) , exceed 54 mg per day Females childbearing potential must negative serum beta Human Chorionic Gonadotropin pregnancy test A history mental retardation would indicate subject function age appropriate level intellectually A recent history suspect substance abuse dependence disorder Subject take Strattera Clinical sign symptom skin irritation hyper/hypopigmentation potential application site</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>